Cite
Textor A, Grunewald L, Anders K, et al. CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus. Cancers (Basel). 2021;13(5)doi: 10.3390/cancers13051050.
Textor, A., Grunewald, L., Anders, K., Klaus, A., Schwiebert, S., Winkler, A., Stecklum, M., Rolff, J., Henssen, A. G., Höpken, U. E., Eggert, A., Schulte, J. H., Jensen, M. C., Blankenstein, T., & Künkele, A. (2021). CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus. Cancers, 13(5), . https://doi.org/10.3390/cancers13051050
Textor, Ana, et al. "CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus." Cancers vol. 13,5 (2021). doi: https://doi.org/10.3390/cancers13051050
Textor A, Grunewald L, Anders K, Klaus A, Schwiebert S, Winkler A, Stecklum M, Rolff J, Henssen AG, Höpken UE, Eggert A, Schulte JH, Jensen MC, Blankenstein T, Künkele A. CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus. Cancers (Basel). 2021 Mar 02;13(5). doi: 10.3390/cancers13051050. PMID: 33801448; PMCID: PMC7958604.
Copy
Download .nbib